Favourite Existing Pharma Clusters in INDIA

MIHAN- A well Preferred Destination

Maharashtra Pharma Hub Over 500 Units are operating in Mumbai, Amravati,

Nagpur, Aurangabad, Nasik, Raigad, Ratnagiri, Thane in Maharashtra .

Over 120 Pharmaceutical Colleges in Maharashtra alone are making around 15000 Expert Graduates every year.

Excellent Weather Conditions & Social harmony

Strategically Excellent Location for Long Term Perspective

Nagpur : Logistic Connectivity

Advantage Nagpur

• Second Capital of the State

• Population of 3.1 million with 70% urban population

• Abundant water & power supply

• Low manpower costs

• High quality Technical & Educational facilities

• Only multi-product SEZ which is adjacent to an existing international airport

• Strong backward linkages

• Strong urban & social infrastructure

• Well-suited weather dynamics with Low Humidity

• Less prone to earth-quake(Seismic Zone II)One of the greenest city of India

Dry Port at Sindi in WardhaArea Approx. 142 Ha (350 acre)

Investment @500 cr (65 Mn Euro)

Facilities for EXIM based industries such as:

Office of Central Drug Standard Control Org.

Custom clearance

Container freight station

Warehousing

Cold storage

Liquid storage

Truck terminal

Dry Port at Sindi in WardhaEstimated traffic generation around 30000 TEUs by 2030

Bhumi Pujan on 2nd October 2017, phase I to be ready within one year.

Dry Port is about 30 km from MIHAN

Connected with Samruddhi Corridor, Central Railway, National Highway

Nagpur–Mumbai Samriddhi Expressway

Length:700 Km

Est. Cost:46,000 Crore

.

A Highway to integrate Vidharbha and Marathwada with rest of Maharashtra

Advantage MIHAN

• Proximity to International Airport

• Adjacent to National Highway

• Connected with Nagpur Metro Rail

• Functioning SEZ

• Long term lease for 99 years in SEZ and 66 years in Non-SEZ area of MIHAN

• Hassle free allotment process

• Premier Institutes like IIM, AIIMS and Govt. Engg. College in MIHAN

MIHAN - OverviewMaharashtra Airport Development Co. Ltd (MADC) is a NodalAgency & a Special Planning Authority for MIHAN

Project Area – 4,061 Ha., Project Cost - $1.2 billion

Brief Area Allocation

International Airport & Allied Activities/ Services

1388.16

Defence & Allied Activities / Services 400.00

Public / Semi Public Area 23.90

Special Economic Zone- Processing Area 1236.21

Mixed Use- Outside SEZ Processing Area 1013.20

Grand Total 4061.47

MIHAN- World Class Infrastructure

• 6 Lane Roads with Street Lights

• Water Supply sourced from Dam at 15 km

• Water Treatment Plant - Clean water supply

• 100 MTPA Sewage Treatment Plant

• 245 MW Thermal Power plant. Power

supplied at Flat Rate of about Rs. 4.5/unit,

• Free services of Dedicated Fire Station

• Functional Storm Water Drainage

• Telecommunication network with OFC

Concessions /Subsidies of SEZDuty free import / domestic procurement of Goods for development, operation and maintenance of SEZ units at MIHAN

100% Income Tax exemption – 1st 5 yrs

50% Next 5 years

50% of the ploughed back profit for the next 5 years

External commercial borrowing up to US$500 million in a year without any maturity restriction through recognized banking channels.

Domestic Procurement exempted from GST

Concessions /Subsidies of SEZ

Power at a concessional rate.

Business Incubation at nominal Fee at CFB

Single window clearance for Central and State level

approvals

Exemption from State tax and other levies as

extended by the State Government

100% FDI allowed & Public Utility Service (PUS) status

Present Status- Indian Pharma Mkt Potential 55 Bn USD by 2020

Compounded Annual growth 15.92%

Expected to be top 3rd by incremental growth & 6th

largest market globally in absolute size

3,000 Pharma companies with 10,500 mfg units

60 therapeutic categories. Over 60,000 generic brands

Largest exporter of Generic medicines globally

Indian vaccines are exported to 150 countries

Health Care to rise annually by 29%

Present Status- Indian Pharma Mkt Great Potential for Medical Tourism

100% FDI allowed for Greenfield Pharma projects

74% FDI for Brownfield Pharma projects

Govt. allocation for Health- USD 8 billion

New Health centres of USD 185 Million

Govt. funded Healthcare Insurance- USD 7,700 /family

Tax deduction of 200% for R&D for capital and revenue

expenditure incurred on scientific research

E-Governance• Digitalization of Drugs Licensing system for manufacturing and sale

of drugs since 2012

• Paperless online system for WHO-GMP Certification from 15th August,2012.

• Laboratory receipts, coding, issue of test reports online.

• Implemented Right to Services Act and notified timelines for theprocessing of the approvals application.

• Interface between Industry Development Department and Industriesto facilitate new pharma investments.

State FDA Initiatives

The quest of ideal location for happily ends at

MIHAN

Come & invest with us,

we will be there with you for every support